Atlas Trials

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

Clinical trial NCT06879340 · RECRUITING

Trial details

NCT number
NCT06879340
Sponsor
University of Kansas Medical Center
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
B-Cell Non-Hodgkin LymphomaB-cell Acute Lymphoblastic Leukemia
Start date
2025-03-31
Primary completion
2030-03-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.